These findings were consistent with ourresults and provided theoretical and clinical support for our conclusions.Therefore, the CALLY index, based on CRP, albumin, and lymphocyte levels, is apowerful and effective prognostic biomarker for CAD patients who have undergonePCI. Here, CRP is linked to coronary artery disorder.